13F Holdings
中文EN

ELMD Electromed, Inc.

Electromedical & Electrotherapeutic Apparatus · NYSE · SEC CIK 1488917 · Fiscal year ends 06/30

Financial factors as of 2026-09-30 (2027Q1), TTM = sum of the last four quarters

Growth

TTM revenue YoY14.1%
TTM net income YoY45.5%
TTM EPS YoY45.7%
Revenue 3-yr CAGR15.0%
Net income 3-yr CAGR54.4%

Margins

Gross margin79.0%
Operating margin19.5%
Net margin15.8%
FCF margin11.5%
EBITDA margin20.6%

Returns

ROE24.5%
ROA20.8%
ROIC (approx.)34.3%
Asset turnover1.32x

Leverage & solvency

Liabilities / assets14.1%
Debt / equity0.00x
Current ratio7.19x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.83x
Accruals ratio3.6%
Payout ratio—
Capex / revenue1.5%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20262026-06-30FY20252025-06-30FY20242024-06-30FY20232023-06-30FY20222022-06-30
Income statement
Revenue$73.78M$64.00M$54.72M$48.07M$41.66M
Cost of revenue$15.83M$14.03M$12.99M$11.55M$10.22M
Gross profit$57.94M$49.97M$41.73M$36.52M$31.44M
R&D expense$1.31M$996,000$656,000$916,000$1.36M
SG&A expense$42.75M$39.31M$34.49M$31.59M$27.11M
Operating income$13.88M$9.66M$6.58M$4.01M$2.97M
Pretax income$14.36M$10.28M$7.04M$4.09M$3.00M
Income tax$3.06M$2.75M$1.89M$920,000$692,000
Net income$11.30M$7.54M$5.15M$3.17M$2.31M
EBITDA$14.75M$10.70M$7.37M$4.56M$3.48M
EPS (basic)1.370.890.600.370.27
EPS (diluted)1.300.850.580.360.26
Weighted avg. shares (diluted)8.69M8.91M8.86M8.70M8.77M
Banking
Net interest income——$455,000$78,000$25,000
Balance sheet
Cash & equivalents$20.45M$15.29M$16.08M$7.37M$8.15M
Receivables$29.80M$24.66M$23.33M$24.13M$21.05M
Inventory$3.68M$3.30M$3.71M$4.22M$3.18M
Current assets$57.37M$45.08M$44.17M$37.79M$34.54M
PP&E, net$5.21M$4.71M$5.17M$5.67M$4.57M
Intangibles$379,000$371,000$657,000$605,000$599,000
Total assets$66.27M$53.80M$52.23M$45.81M$41.36M
Current liabilities$12.22M$10.47M$7.68M$8.05M$7.15M
Total liabilities$12.29M$10.59M$7.69M$8.14M$7.19M
Shareholders' equity$53.98M$43.21M$44.55M$37.67M$34.17M
Shares outstanding8.37M8.35M8.64M8.56M8.48M
Cash flow statement
Operating cash flow$9.66M$11.39M$9.07M$1.31M-$686,000
Capital expenditure$1.25M$262,000$287,000$1.65M$1.43M
Free cash flow$8.41M$11.13M$8.78M-$333,000-$2.11M
Investing cash flow-$1.30M-$306,000-$395,000-$1.72M-$1.52M
Financing cash flow-$3.20M-$11.88M$36,000-$380,000-$1.52M
Depreciation & amortization$868,000$1.04M$789,000$550,000$503,000
Stock-based compensation$2.72M$3.06M$1.69M$708,000$976,000
Share buybacks$3.92M$10.00M$275,000$153,000$1.45M

Free plan shows the latest 5 periods; Pro shows all 16 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.